← All organizations

Generon (Shanghai) Corporation Ltd.

For profitWebsite ↗

Also known as: Generon (Shanghai) Corporation Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 15, 2019

Defunct as of Dec 31, 2025

Timeline

2000s

Jun 1, 2004
Generon (Shanghai) Corporation Ltd.— Founded

2020s

Dec 31, 2025
Generon (Shanghai) Corporation Ltd.— Defunct

Drugs by trial phase (10 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

A-319

Indications

Studied for

Recent trials (10)

NCT04056975Lead sponsorPhase 1Sep 15, 2019
NCT04174599Lead sponsorPhase 3Apr 12, 2018
NCT03252431Lead sponsorPhase 3Feb 28, 2018
NCT02872103Lead sponsorPhase 3Aug 1, 2016
NCT02406651Study directorPhase 1/Phase 2May 12, 2016
NCT02406651Lead sponsorPhase 1/Phase 2May 12, 2016
NCT02521441Lead sponsorPhase 2May 1, 2014
NCT02522234Lead sponsorPhase 1/Phase 2Mar 1, 2014
NCT02527746Lead sponsorPhase 1/Phase 2Dec 1, 2012
NCT01648322Lead sponsorPhase 2Jun 1, 2012

Details

Founded: Shanghai, CN Jun 1, 2004
Last known activity: Sep 15, 2019